Metformin Renders Survival Advantage to Patients with Glioblastoma Multiforme
<b>Purpose</b>: Glioblastoma multiforme (GBM) is a highly aggressive cancer with limited survival despite current treatments. Rising treatment costs highlight the importance of identifying more affordable therapeutic alternatives. A body of literature has shown that metformin has the potential to ac...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
MDPI AG
2026-02-01
|
| Seri Bilgileri: | Neurology International |
| Konular: | |
| Online Erişim: | https://www.mdpi.com/2035-8377/18/3/40 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|